Buzz On The Street

FOLLOW US

NEWEST

Ultragenyx (RARE) Stock Sinks 25%

Ultragenyx (RARE) Stock Sinks 25%

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is taking a sharp hit in premarket trading Thursday, with shares falling as much as 25% after the company delivered an underwhelming clinical trial update late Wednesday. The news centered around its late-stage trial of...

COMMODITIES

LIVE FOREX RATES